Large-scale testing (Phase 3)Ended earlyNCT00312442What this trial is testingPhase II/III Study of WST09 in Prostate Cancer After Radiation TherapyWho this might be right forProstate Cancer STEBA France 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04190446What this trial is testingEvaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate CancerWho this might be right forMetastatic Prostate AdenocarcinomaOligometastatic Prostate CarcinomaProstate Adenocarcinoma+2 more Mayo Clinic 84
Large-scale testing (Phase 3)Ended earlyNCT00014586What this trial is testingBicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer European Organisation for Research and Treatment of Cancer - EORTC 110
Testing effectiveness (Phase 2)Study completedNCT00040586What this trial is testingPhase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2Who this might be right forProstatic Neoplasms BZL Biologics
Not applicableUnknownNCT04245670What this trial is testing5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:Who this might be right forProstate Cancer Sunnybrook Health Sciences Centre 75
Testing effectiveness (Phase 2)Ended earlyNCT01093183What this trial is testingLenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate CancerWho this might be right forAdenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer University of Nebraska 25
Testing effectiveness (Phase 2)Looking for participantsNCT06893783What this trial is testingEfficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma PatientsWho this might be right forNeuroendocrine Carcinomas (NEC)Neuroendocrine Carcinoma of PancreasNeuroendocrine Carcinoma of Prostate Inkeun Park 60
Early research (Phase 1)Looking for participantsNCT07316686What this trial is testingPhase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate AdenocarcinomaWho this might be right forProstate Cancer (Adenocarcinoma) Instituto do Cancer do Estado de São Paulo 18
Large-scale testing (Phase 3)Study completedNCT00023686What this trial is testingSurgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerWho this might be right forProstate Cancer Alliance for Clinical Trials in Oncology 190
Not applicableStudy completedNCT02846870What this trial is testingVisually Enhanced Education About Prostate CancerWho this might be right forStage I Prostate CancerStage II Prostate CancerStage III Prostate Cancer Vanderbilt-Ingram Cancer Center 30
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03367702What this trial is testingStereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate CancerWho this might be right forStage II Prostate Adenocarcinoma AJCC v7 NRG Oncology 692
Large-scale testing (Phase 3)Ended earlyNCT00003645What this trial is testingRandomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceWho this might be right forProstate Cancer M.D. Anderson Cancer Center 64
Not applicableEnrolling By InvitationNCT06834204What this trial is testingAdvancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsWho this might be right forCancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more Rutgers, The State University of New Jersey 266
Early research (Phase 1)Looking for participantsNCT05656573What this trial is testingCART-PSMA Cells for Advanced Prostate CancerWho this might be right forProstate Cancer Nova Therapeutics LLC 20
Not applicableStudy completedNCT01540994What this trial is testingStereotactic Body Radiation Therapy (SBRT) for Prostate CancerWho this might be right forProstatic Neoplasm Sharp HealthCare 12
Large-scale testing (Phase 3)Looking for participantsNCT07028853What this trial is testingThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Who this might be right forMetastatic Castration Sensitive Prostate Cancer (mCSPC)Hormone Sensitive Prostate CancerProstate Cancer+1 more Pfizer 1,000
Early research (Phase 1)Ended earlyNCT00313456What this trial is testingA Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly DocetaxelWho this might be right forTumorsProstate Cancer Agennix 25
Not applicableStudy completedNCT01366053What this trial is testingHormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH AgonistsWho this might be right forProstate Cancer CMX Research 125
Early research (Phase 1)Active Not RecruitingNCT07038369What this trial is testingATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsWho this might be right forAdvanced Solid TumorsBreast CancerBreast Carcinoma+24 more Atavistik Bio, Inc 134